Pay in 4 interest-free payments of $7.18 Learn more
:max_bytes(150000):strip_icc()/26Q1_WL_oral-sema_newsroom_1920x1008-1dfa18327b724266bed50c36ab0b9d49.jpg)
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
JAMA Intern Med 182 , 513519 (2022)
S., & Shufelt, C
A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: The ERGO (etomoxir for the recovery of glucose oxidation) study
A meta-analysis of seven SURPASS clinical trials in participants with T2DM showed the hazard ratios comparing tirzepatide versus controls of 0.80 (95% CI, 0.57 1.11) for 4-MACE, 0.90 (95% CI, 0.50 1.61) for cardiovascular death, and 0.80 (95% CI, 0.51 1.25) for all-cause mortality (264)
US$ 24.20
US$ 28.80
US$ 20.66
US$ 22.05
US$ 20.77
